Navigation Links
New system devised to guide doctors treating patients with symptomatic myocardial bridging
Date:6/26/2008

nto three categories:

  • 58 were in class A Having clinical symptoms but no objective signs of ischemia.
  • 62 were in class B Having clinical symptoms and objective signs of ischemia by non-invasive stress tests.
  • 37 were in class C Having clinical symptoms and objective altered intracoronary hemodynamics, based on angiography and intracoronary Doppler with or without signs of ischemia by non-invasive stress tests.

Based on initial observations and five-year follow-up, the cardiologists propose a new diagnostic work-up and therapeutic strategy:

Type A: No further diagnostic work or therapy is needed. Nitrates should be avoided. In rare cases, beta-blockers might be considered temporarily to relieve symptoms.

Type B: Initiate beta-blockers or calcium channel blockers. If symptoms are not relieved, quantitative coronary angioplasty or invasive blood-flow studies should be performed, after which stenting may be considered if there is objective evidence of reduced blood flow to the heart muscle.

Type C: Initiate beta-blockers or calcium channel blockers. If symptoms are refractory, consider stenting of the bridged segment.

"One of the our most important recommendations is that Type C patients those with hemodynamic changes always be treated, regardless of results of non-invasive stress testing," Schwarz said, adding that the authors believe the new classification system will enable cardiologists worldwide to better risk-stratify and treat patients with this frequent congenital coronary anomaly.


'/>"/>

Contact: Sandy Van
sandy@prpacific.com
800-880-2397
Cedars-Sinai Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Different method of evaluating the urinary tract system reduces radiation dose
2. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
3. Exempla Healthcare Contracts For Talismans Quality Donor System
4. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
5. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
6. Plexus Systems Ranks in Top Third of the 2007 Inc. 5,000 with Three-Year Sales Growth of 226%
7. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
8. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
11. NAMSA Deploys TrackWise Software as its Quality Management System
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Heat Therapy May Help Prevent Esophageal Cancer 2Health News:New therapy enlists immune system to boost cure rate in a childhood cancer 2Health News:More Living Longer With Advanced Colon Cancer 2Health News:More Living Longer With Advanced Colon Cancer 3Health News:William W. Wirtz Allocates $19.5 Million to Northwestern Memorial for Cancer Care and Research 2Health News:William W. Wirtz Allocates $19.5 Million to Northwestern Memorial for Cancer Care and Research 3Health News:William W. Wirtz Allocates $19.5 Million to Northwestern Memorial for Cancer Care and Research 4Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 2Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 3Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 4Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 5Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 6Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 7Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 8
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 1Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 2Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 3Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 1Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 2Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 3Horizon Therapeutics Names Dr Jeffrey W Sherman Executive Vice President and Chief Medical Officer 12821 1Horizon Therapeutics Names Dr Jeffrey W Sherman Executive Vice President and Chief Medical Officer 12821 2